Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-29 4:54 pm Purchase | 2023-09-19 | 13G | Chimerix, Inc. CMRX | RA Capital Management, L.P. | 6,501,624 7.300% | 6,501,624![]() (New Position) | Filing History |
| 2023-09-25 4:30 pm Purchase | 2023-09-21 | 13D | ARS Pharmaceuticals, Inc. SPRY | RA Capital Management, L.P. | 9,459,678 9.900% | 2,700,000![]() (+39.94%) | Filing History |
| 2023-09-22 4:30 pm Purchase | 2023-09-12 | 13G | CymaBay Therapeutics, Inc. CBAY | RA Capital Management, L.P. | 6,940,000 6.200% | 6,940,000![]() (New Position) | Filing History |
| 2023-09-19 5:25 pm Sale | 2023-09-15 | 13D | Cytek Biosciences, Inc. CTKB | RA Capital Management, L.P. | 6,809,404 4.990% | -6,329,923![]() (-48.18%) | Filing History |
| 2023-08-31 5:25 pm Purchase | 2023-08-29 | 13D | ARS Pharmaceuticals, Inc. SPRY | RA Capital Management, L.P. | 6,759,678 7.070% | 5,017,492![]() (+288.00%) | Filing History |
| 2023-08-25 5:01 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | RA Capital Management, L.P. | 18,690,868 9.990% | 18,690,868![]() (New Position) | Filing History |
| 2023-08-21 4:30 pm Purchase | 2023-08-10 | 13G | Gracell Biotechnologies Inc. GRCL | RA Capital Management, L.P. | 48,600,300 9.990% | 48,600,300![]() (New Position) | Filing History |
| 2023-08-17 4:30 pm Purchase | 2023-08-07 | 13G | Nektar Therapeutics NKTR | RA Capital Management, L.P. | 1,246,667 9.800% | 1,246,667![]() (New Position) | Filing History |
| 2023-08-14 5:01 pm Sale | 2023-08-14 | 13G | BELLUS Health Inc. BLU | RA Capital Management, L.P. | 0 0.000% | -12,452,574![]() (Position Closed) | Filing History |
| 2023-08-14 5:00 pm Sale | 2023-08-14 | 13G | Kinnate Biopharma Inc. KNTE | RA Capital Management, L.P. | 0 0.000% | -4,264,144![]() (Position Closed) | Filing History |
| 2023-08-11 5:05 pm Purchase | 2023-08-10 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 1,139,017 33.700% | 1,010![]() (+0.09%) | Filing History |
| 2023-08-11 5:01 pm Sale | 2023-08-09 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 12,874,814 16.700% | -2,084![]() (-0.02%) | Filing History |
| 2023-08-09 5:00 pm Sale | 2023-08-09 | 13D | DICE Therapeutics, Inc. DICE | RA Capital Management, L.P. | 0 0.000% | -7,877,862![]() (Position Closed) | Filing History |
| 2023-08-01 4:30 pm Purchase | 2023-06-08 | 13G | NewAmsterdam Pharma Company N.V. NAMS | RA Capital Management, L.P. | 9,333,333 11.300% | 5,000,000![]() (+115.38%) | Filing History |
| 2023-07-25 4:31 pm Purchase | 2023-07-21 | 13D | Acumen Pharmaceuticals, Inc. ABOS | RA Capital Management, L.P. | 14,981,618 25.900% | 5,207,067![]() (+53.27%) | Filing History |
| 2023-07-06 4:32 pm Purchase | 2023-06-26 | 13G | Talaris Therapeutics, Inc. TALS | RA Capital Management, L.P. | 233,318 5.500% | 233,318![]() (New Position) | Filing History |
| 2023-07-06 4:30 pm Purchase | 2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY | RA Capital Management, L.P. | 347,069 9.990% | 347,069![]() (New Position) | Filing History |
| 2023-06-27 5:00 pm Purchase | 2023-06-26 | 13D | Aerovate Therapeutics, Inc. AVTE | RA Capital Management, L.P. | 236,947 30.000% | 833![]() (+0.35%) | Filing History |
| 2023-06-21 5:00 pm Purchase | 2023-06-18 | 13D | DICE Therapeutics, Inc. DICE | RA Capital Management, L.P. | 7,877,862 16.500% | 217,247![]() (+2.84%) | Filing History |
| 2023-06-12 5:00 pm Sale | 2023-06-08 | 13D | Satsuma Pharmaceuticals, Inc. STSA | RA Capital Management, L.P. | 0 0.000% | -5,944,252![]() (Position Closed) | Filing History |

